share_log

UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

烏龍製藥 | 8-K:UroGen Pharma 公佈 2024 年第三季度財務業績和業務亮點,包括可能在 2025 年推出 UGN-102
美股SEC公告 ·  2024/11/06 08:07
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息